'Renal-dose' dopamine for the treatment of acute renal failure: Scientific rationale, experimental studies and clinical trials

Kidney International

Volumn 50, Issue 1, 1996, Pages 4-14

  Denton, Mark D ^b   Chertow, Glenn M ^b   Brady, Hugh R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; FUROSEMIDE; GAMMA GLUTAMYLDOPA; MANNITOL;

ACUTE KIDNEY FAILURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DOSE RESPONSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPOKALEMIA; HYPOPHOSPHATEMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BLOOD FLOW; META ANALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SODIUM EXCRETION; TACHYCARDIA; TREATMENT OUTCOME;

EID: 0029812050     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.280     Document Type: Article

References (79)

1. THOMPSON BT, COCKRILL BA: Renal-dose dopamine: A siren song? Lancet 344:7-8, 1994
2. VINCENT JL: Renal effects of dopamine: Can our dream ever come true? Crit Care Med 22:5-6, 1994
3. SZERLIP H: Renal-dose dopamine: Fact and fiction. Ann Intern Med 115:153-154, 1991
4. GOLDBERG L: Cardiovascular and renal implications of dopamine: Potential clinical applications. Pharmacol Rev 24:1-29, 1972
5. KAPUSTA DR, ROBIE NW: Plasma dopamine in regulation of canine renal blood flow. Am J Physiol 255:R379-R387, 1988
6. CAREY RM, SIRAGY HM, RAGSDALE NV, HOWELL NL, FELDER RA, PEACH MJ, CHEVALIER RL: Dopamine-1 and dopamine-2 mechanisms in the control of renal function. Am J Hypertens 3:59S-63S, 1990
7. HOLLENBERG N, ADAMS D, MENDALL P, ABRAMS H, MERRIL J: Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man. Clin Sci 45:733-742, 1973
8. STEVENS P, GWYTHER S, BOULTEE J: Practical use of duplex doppler analysis of the renal vasculature in critically ill patients. Lancet I:240, 1989
9. BUGHI S, HORTON R, ANTONIPILLAI I, MANOOGIAN C, EHRLICH L, NADLER J: Comprison of dopamine and fenoldapam effects on renal blood flow and prostacyclin excretion in normal and hypertensive subjects. J Clin Endocrinol Metab 69:1116-1121, 1989
10. LEE MR: Dopamine and the kidney: Ten years on. Clin Sci 84:357-375, 1993
11. TER WEE P, SMIT AJ, ROSMAN JB, SLUITER WJ, DONKER AJ: Effect of intravenous infusion of low-dose dopamine on renal function in normal individuals and in patients with renal disease. Am J Nephrol 6:42-46, 1986
12. CHRISTIANSEN JS, PEDERSEN MM, SCHMITZ A, CHRISTENSEN CK, CHRISTENSEN T, MOGENSEN CE: Low-dose dopamine infusion, renal haemodynamics and urinary albumin excretion rate in insulin-dependent diabetics and in normal man. Scand J Clin Lab Invest 48:679-683, 1988
13. HUGHES J, BECK T, ROSE C JR, CAREY R: The effect of selective dopamine-1 stimulation on renal and adrenal function in man. J Clin Endocrinol Metab 66:518-525, 1988
14. MCDONALD R, GOLDBERG L, MCNAY J, TUTTLE E: Effects of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate and renal plasma flow. J Clin Invest 43:1116-1124, 1964
15. ORME M, BRECKENRIDGE A, DOLLERY C: The effects of long term administration of dopamine on renal function in hypertensive patients. Eur J Clin Pharmacol 6:150-155, 1973
16. LEVINSON PD, GOLDSTEIN DS, MUNSON PJ, GILL JJ, KEISER HR: Endocrine, renal, hemodynamic responses to graded dopamine infusions in normal men. J Clin Endocrinol Metab 60:821-826, 1985
17. BRAUN GG, BAHLMANN F, BRANDL M, KNOLL R: Long term administration of dopamine: Is there a development of tolerance? Prog Clin Biol Res 308:1097-1099, 1989
18. AGNOLI GC, CACCIARI M, GARUTTI C, IKONOMU E, LENZI P, MARCHETTI G: Effects of extracellular fluid volume changes on renal response to low-dose dopamine infusion in normal women. Clin Physiol 7:465-79, 1987
19. SIRAGY HM, FELDER RA, HOWELL NE, CHEVALIER RL, PEACH MJ, CAREY RM: Intrarenal dopamine acts at the dopamine-1 receptor to control renal function. J Hypertens 6:S479-S481, 1988
20. BAINES AD, CHAN W: Production of urine free dopamine from DOPA; a micropuncture study. Life Sci 26:253-259, 1980
21. HAYASHI M, YAMAJI Y, KITAJIMA W, SARUTA T: Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Physiol 258:F28-F33, 1990
22. CAREY R, VAN LOON G, BAINES A, ORTT E: Decreased plasma and urinary dopamine during dietary sodium depletion in man. J Clin Endocrinol Metab 52:903-909, 1981
23. GOLDSTEIN D, SHILL R, EISENHOFER G, GILL J: Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci 76:517-522, 1989
24. GROSSMAN E, GOLDSTEIN DS, HOFFMAN A, WACKS IR, EPSTEIN M: Effects of water immersion on sympathoadrenal and dopa-dopamine systems in humans. Am J Physiol 262:993-999, 1992
25. +-ATPase activity is inhibited during high-salt diet: Evidence for DA-mediated effect. Am J Physiol 254:F795-F801, 1988
26. JEFFREY RF, MACDONALD TM, MARWICK K, LEE MR: The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man. Br J Clin Pharmacol 25:195-201, 1988
27. + ATPase activity in rat proximal convoluted tubule segments. Am J Physiol 252:F39-F45, 1987
28. +-ATPase activity in rat renal cortical tubule cells. Am J Physiol 255:F666-F673, 1988
29. SIRAGY HM, FELDER RA, HOWELL NL, CHEVALIER RL, PEACH MJ, CAREY RM: Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 257:F469-F477, 1989
30. FELDER CC, MCKELVEY AM, GITLER MS, EISNER GM, JOSE PA: Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int 36:183-193, 1989
31. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol 259:F297-F302, 1990
32. FELDER CC, ALBRECHT F, EISNER GM, JOSE PA: The signal transducer for the dopamine-1 regulated sodium transport in renal cortical brush border membrane vesicles. Am J Hypertens 3:S47-S52, 1990
33. CHEN CJ, LOKHANDWALA MF: Role of endogenous dopamine in the natriuretic response to various degrees of iso-osmotic volume expansion in rats. Clin Exper Hypertens 13:1117-1126, 1991
34. + antiport activity in rat renal cortical brush border membrane vesicles. Clin Exp Hypertens 14:653-666, 1992
35. BAINES AD, Ho P, DRANGOVA R: Proximal tubular dopamine production regulates basolateral Na-K-ATPase. Am J Physiol 262:F566-F571, 1992
36. MEISTER B, APERIA A: Molecular mechanisms involved in catecholamine regulation of sodium transport. Semin Nephrol 13:41-49, 1993
37. +)-ATPase activity in thedeveloping rat renal cortical and medullary tubule cells. Pediatr Res 34:308-311, 1993
38. MUTO S, TABEI K, ASANO Y, IMAI M: Dopaminergic inhibition of the action of vasopressin on the cortical collecting tubule. EurJ Pharmacol 114:393-397, 1985
39. BRADY HR, BRENNER BM: Acute renal failure, in Harrison's Principles of Internal Medicine, New York, McGraw Hill, Inc., 1994, pp 1264-1270
40. BRADY HR, BRENNER BM, LIEBERTHAL W: Acute renal failure, in The Kidney (5th ed), edited by BRENNER BM, Philadelphia, W.B. Saunders Co., 1996, pp. 1200-1252
41. LINDNER A, CUTLER RE, GOODMAN G: Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 16:158-166, 1979
42. HAMMOND JJ, OVERTURE ML, KIRKENDALL WM: Preliminary observations concerning the effect of dopamine on uranyl nitrate induced renal failure. Experientia 35:1630-1631, 1979
43. GOLDFARB D, IAINA A, SERBAN I, GAVENDO S, ELIAHOU HE: Dopamine in the early recovery phase of acute ischemic renal failure in rats. Isr J Med Sci 17:1069-1071, 1981
44. IAINA A, SOLOMON S, GAVENDO S, ELIAHOU HE: Reduction in severity of acute renal failure in rats by dopamine. Biomedicine 27:137-139, 1977
45. CASSON IF, CLAYDEN DA, COPE GF, LEE MR: The protective effect of gamma-glutamyl L-dopa on the glycerol treated rat model of acute renal failure. Clin Sci 65:159-164, 1983
46. CONGER JD, FALK SA, YUAN BH, SCHRIER RW: Atrial natriuretic peptide and dopamine in a rat model of ischemic acute renal failure. Kidney Int 35:1126-1132, 1989
47. PASS LJ, EBERHART RC, BROWN JC, ROHN GN, ESTRERA AS: The effect of mannitol and dopamine on the renal response to thoracic aortic cross-clamping. J Thorac Cardiovasc Surg 95:608-612, 1988
48. CONGER JD, FALK SA, HAMMOND WS: Atrial natriuretic peptide and dopamine in established acute renal failure in the rat. Kidney Int 40:21-28, 1991
49. BALDWIN L, HENDERSON A, HICKMAN P: Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 120:744-747, 1994
50. MYLES PS, BUCKLAND MR, SCHENK NJ, CANNON GB, LANGLEY M, DAVIS BB, WEEKS AM: Effect of "renal-dose" dopamine on renal function following cardiac surgery. Anaesth Intens Care 21:56-61, 1993
51. SWYGERT TH, ROBERTS LC, VALEK TR, BRAJTBORD D, BROWN MR, GUNNING TC, PAULSEN AW, RAMSAY MA: Effect of intraoperative low-dose dopamine on renal function in liver transplant recipients. Anesthesiology 75:571-576, 1991
52. POLSON RJ, PARK GR, LINDOP MJ, FARMAN JV, CALNE RY, WILLIAMS R: The prevention of renal impairment in patients undergoing orthotopic liver grafting by infusion of low dose dopamine. Anaesthesia 42:15-19, 1987
53. PARKS RW, DIAMOND T, MCCRORY DC, JOHNSTON GW, ROWLANDS BJ: Prospective study of postoperative renal function in obstructive jaundice and the effect of perioperative dopamine. Br J Surg 81:437-439, 1994
54. HALL KA, WONG RW, HUNTER GC, CAMAZINE BM, RAPPAPORT WA, SMYTH SH, BULL DA, MCINTYRE KE, BERNHARD VM, MISIOROWSKI RL: Contrast-induced nephrotoxicity: The effects of vasodilator therapy. J Surg Res 53:317-320, 1992
55. WEISBERG LS, KURNIK PB, KURNIK BR: Dopamine and renal blood flow in radiocontrast-induced nephropathy in humans. Renal Failure 15:61-68, 1993
56. GRUNDMANN R, KINDLER J, MEIDER G, STOWE H, SIEBERTH HG, PICHLMAIER H: Dopamine treatment of human cadaver kidney graft recipients: A prospectively randomized trial. Klinische Wochenschr 60:193-197, 1982
57. SANDBERG J, TYDEN G, GROTH CG: Low-dose dopamine infusion following cadaveric renal transplantation: No effect on the incidence of ATN. Transplant Proc 24:357, 1992
58. KADIEVA VS, FRIEDMAN L, MARGOLIUS LP, JACKSON SA, MORRELL DF: The effect of dopamine on graft function in patients undergoing renal transplantation. Anesthes Analges 76:362-365, 1993
59. PASCUAL E, GOMEZ-ARNAU J, PENSADO A, DE LA QUINTANA B, CARRERA A, ARRIBAS MJ, GARCIA GM, CUERVAS MV: Incidence and risk factors of early acute renal failure in liver transplant patients. Transplant Proc 25:1837, 1993
60. POPLAWSKI S, GONWA T, GOLDSTEIN R, HUSBERG B, KLINTMALM G: Long term nephrotoxicity in liver transplantation. Transplant Proc 21:2469-2471, 1989
61. DELOSANGELES A, BAQUERO A, BANNETT A, RAJA R: Dopamine and furosemide infusion for prevention of post-transplant oliguric renal failure. (abstract) Kidney Int 27:339, 1985
62. BARRETT B, PARFREY P, VAVASOUR H, O'DEA F, KENT G, STONE E: A comparison of nonionic, low osmolalily radiocontrast agents with ionic, high osmolality agents during cardiac catheterization, N Engl J Med 326:431-436, 1992
63. HENDERSON IS, BEATTIE TJ, KENNEDY AC: Dopamine hydrochloride in oliguric states. Lancet 2:827-828, 1980
64. PARKER S, CARLON G, ISAACS M, HOWLAND W, KAHN R: Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 9:630-632, 1981
65. DAVIS RF, LAPPAS DG, KIRKLIN JK, BUCKLEY MJ, LOWENSTEIN E: Acute oliguria after cardiopulmonary bypass: Renal functional improvement with low-dose dopamine infusion. Crit Care Med 10:852-856, 1982
66. GRAZIANI G, CASATI S, CANTALUPPI A, CITTERIO A, AROLDI A, SCALAMOGNA A, BRANCACCIO D, PONTICELLI C: Dopamine-frusemide therapy in acute renal failure. Proc Eur Dial Transplant Assoc 19:319-324, 1983
67. LINDNER A: Synergism of dopamine and furosemide in diuretic-resistant, oliguric acute renal failure. Nephron 33:121-126, 1983
68. PAUL MD, MAZER CD, BYRICK RJ, ROSE DK, GOLDSTEIN MB: Influence of mannitol and dopamine on renal function during elective infrarenal aortic clamping in man. Am J Nephrol 6:427-434, 1986
69. CONTE G, DAL CA, SABBATINI M, NAPODANO P, DE NL, GIGLIOTTI G, FUIANO G, TESTA A, ESPOSITO C, RUSSO D: Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects. Kidney Int 36:1086-1092, 1989
70. LUMLERTGUL D, KEOPLUNG M, SITPRIJA V, MOOLLAOR P, SUWANGOOL P: Furosemide and dopamine in malarial acute renal failure. Nephron 52:40-44, 1989
71. PALMIERI G, MORABITO A, LAURIA R, MONTESARCHO V, MATONA E, MEMOLI B: Low-dose dopamine induces early recovery of recombinant interleukin-2 impaired renal function. Eur J Cancer 29A:1119-1122, 1993
72. MARIK P: Low-dose dopamine in critically ill oliguric patients: The influence of the renin-angiotensin system. Heart Lung 22:171-175, 1993
73. FLANCBAUM L, CHOBAN P, DASTA J: Quantative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 22:61-66, 1994
74. GRAZIANI G, CANTALUPPI A, CASATI S, CITTERIO A, SCALAMOGNA A, AROLDI A, SILENZIO R, BRANCACCIO D, PONTICELLI C: Dopamine and frusemide in oliguric acute renal failure. Nephron 37:39-42, 1984
75. SCHAER G, FINK M, PARRILLO J: Norepinephrine alone versus norepinephrine plus low dose dopamine: Enhanced renal blood flow with combination pressor therapy. Crit Care Med 13:492-496, 1985
76. EL ALLAF D, CREMERS S, D'ORIO V, CARLIER J: Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure. Arch Int Physiol Biochim 92:S49-S55, 1984
77. GREENE S, SMITH J: Dopamine gangrene. N Engl J Med 294:114-115, 1976
78. SEGAL J, PHANG T, WALLEY K: Low-dose dopamine hastens onset of gut ischemia in a porcine model of hemmorrhagic shock. J Appl Physiol 73:1159-1164, 1992
79. DIBONA GF: Hemodynamic support: Volume management and pharmacological cardiovascular support. Semin Nephrol 14:33-40, 1994